The expression of five of the eight GMII genes (TALDO1, AHCY, FASN, GALK1 and SLC7A9) in bladder cancer tissues was higher than that in normal tissues, while ENPP1, CYP19A1 and HSPG2 were down-regulated in tumor tissues (p < 0.05) (Figure S2A). The gene discussed is FASN; the disease is urinary bladder cancer.